Atria Wealth Solutions Inc. Reduces Stock Holdings in Danaher Co. (NYSE:DHR)

Atria Wealth Solutions Inc. reduced its holdings in Danaher Co. (NYSE:DHR - Free Report) by 11.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,337 shares of the conglomerate's stock after selling 2,720 shares during the period. Atria Wealth Solutions Inc.'s holdings in Danaher were worth $4,900,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher during the 4th quarter worth about $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher during the 4th quarter worth about $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher during the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC boosted its stake in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent analyst reports. Wolfe Research raised shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target for the company in a research note on Thursday, October 31st. Robert W. Baird lowered their price objective on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Royal Bank of Canada reissued an "outperform" rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Guggenheim initiated coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a "buy" rating and a $275.00 price objective for the company. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and a consensus target price of $278.00.

Danaher Stock Up 1.5 %

Shares of NYSE DHR traded up $3.08 during trading hours on Friday, hitting $211.03. 3,490,719 shares of the stock were exchanged, compared to its average volume of 4,488,012. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market cap of $152.42 billion, a PE ratio of 39.97, a PEG ratio of 2.61 and a beta of 0.83. The firm has a fifty day moving average price of $227.21 and a 200-day moving average price of $247.52. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the firm posted $2.09 EPS. On average, sell-side analysts expect that Danaher Co. will post 7.67 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher's dividend payout ratio is 20.45%.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.